Drugs / ERIBAXABAN
ERIBAXABAN
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00306254 | Mar 2006 → Jul 2007 | venous thromboembolism | Pfizer | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ERIBAXABAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL476186 ↗ |
| Known as | PD 0348292 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00306254 ↗ |
| Known as | PD 348 | ChEMBL registry synonym — accepted as the source's own label CHEMBL476186 ↗ |
| Known as | PD 348,292 | ChEMBL registry synonym — accepted as the source's own label CHEMBL476186 ↗ |
| Modality | Small molecule | — CHEMBL476186 ↗ |